AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Innodata, you have to believe its AI data and services business can keep attracting large, repeat customers while managing heavy client concentration and rising competition. The latest strong quarter and reaffirmed 2026 growth target support the near term growth catalyst, but do little to reduce the key risk that a single large tech customer could materially swing revenue and earnings if spending slows or contracts change.
The new US$300 million at the market equity program is the most relevant development here, because it directly intersects with growth and risk. It could give Innodata more room to fund expansion if large AI and enterprise programs keep scaling, but also raises the possibility of future dilution precisely at a time when expectations are high and execution still has to prove itself across a concentrated customer base.
Yet behind the headline growth, investors should also be aware of the risk that future share issuance and client concentration could both weigh on...
Read the full narrative on Innodata (it's free!)
Innodata's narrative projects $618.6 million revenue and $71.7 million earnings by 2029. This requires 29.7% yearly revenue growth and about a $32.4 million earnings increase from $39.3 million today.
Uncover how Innodata's forecasts yield a $122.75 fair value, a 99% upside to its current price.
The lowest set of analysts painted a much more cautious picture, assuming revenue of about US$623 million and earnings of roughly US$58 million by 2029, which contrasts sharply with the latest upbeat guidance and reminds you that views on Innodata’s concentration and margin risks can differ widely and may shift again as this new earnings and financing update is fully absorbed.
Explore 8 other fair value estimates on Innodata - why the stock might be worth less than half the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Our top stock finds are flying under the radar-for now. Get in early:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com